DanCann Pharma A/S: A strengthened market position after an impressive H2-2022
COPENHAGEN, Denmark, 14 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces that the Company is ready to fulfill its great ambitions after a successful half year.Since the beginning of September, DanCann Pharma has carried out a rights issue and hereby secured another DKK 22 million, has closed export agreements for more than DKK 80 million, has been EU-GMP certified for the production of medical cannabis, has been given the green light for the relocation of the subsidiary CannGros and has been side